IL1A and hepatocellular carcinoma: Inhibition of NK cell activation is associated with IL-1α released from tumor tissues, which also attenuates the killing ability of CD8+ T cells; moreover, IL-1α released from tumors recruits MDSC in the tumor microenvironment and promotes HCC development (97).